Retention of mutant alpha(1)-antitrypsin Z in endoplasmic reticulum is associated with an autophagic response.
Although there is evidence for specific subcellular morphological alterations in response to accumulation of misfolded proteins in the endoplasmic reticulum (ER), it is not clear whether these morphological changes are stereotypical or if they depend on the specific misfolded protein retained. This issue may be particularly important for mutant secretory protein alpha(1)-antitrypsin (alpha(1)AT) Z because retention of this mutant protein in the ER can cause severe target organ injury, the chronic hepatitis/hepatocellular carcinoma associated with alpha(1)AT deficiency. Here we examined the morphological changes that occur in human fibroblasts engineered for expression and ER retention of mutant alpha(1)ATZ and in human liver from three alpha(1)AT-deficient patients. In addition to marked expansion and dilatation of ER, there was an intense autophagic response. Mutant alpha(1)ATZ molecules were detected in autophagosomes by immune electron microscopy, and intracellular degradation of alpha(1)ATZ was partially reduced by chemical inhibitors of autophagy. In contrast to mutant CFTRDeltaF508, expression of mutant alpha(1)ATZ in heterologous cells did not result in the formation of aggresomes. These results show that ER retention of mutant alpha(1)ATZ is associated with a marked autophagic response and raise the possibility that autophagy represents a mechanism by which liver of alpha(1)AT-deficient patients attempts to protect itself from injury and carcinogenesis.
Teckman
J H
JH
Department of Pediatrics, Washington University School of Medicine, Division of Gastroenterology and Nutrition, St. Louis Children's Hospital, St. Louis, Missouri 63110, USA. teckman@kids.wustl.edu
Perlmutter
D H
DH
D000225:Adenine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000818:Animals; D001343:Autophagy / Q000187:drug effects / Q000502:physiology*; D016466:CHO Cells; D006224:Cricetinae; D004721:Endoplasmic Reticulum / Q000737:chemistry / Q000502:physiology* / Q000648:ultrastructure; D005347:Fibroblasts / Q000737:chemistry / Q000166:cytology / Q000378:metabolism; D015870:Gene Expression / Q000502:physiology; D006801:Humans; D008099:Liver / Q000166:cytology / Q000502:physiology; D008107:Liver Diseases / Q000378:metabolism / Q000503:physiopathology; D051379:Mice; D008822:Mice, Transgenic; D016253:Microscopy, Immunoelectron; D008861:Microsomes / Q000737:chemistry / Q000502:physiology / Q000648:ultrastructure; D016296:Mutagenesis / Q000502:physiology; D014617:Vacuoles / Q000737:chemistry / Q000502:physiology / Q000648:ultrastructure; D014746:Vimentin / Q000032:analysis; D000515:alpha 1-Antitrypsin / Q000032:analysis / Q000235:genetics*
C043392:SERPINA1 protein, human; D014746:Vimentin; D000515:alpha 1-Antitrypsin; C025946:3-methyladenine; D000225:Adenine